The clinical effection of thoracoscopic subsegmentectomy in the treatment of peripheral lung cancer
Abstract
Objective: To investigate the clinical effect of thoracoscopic subsegmentectomy in the treatment of patients with early lung cancer. Methods: A retrospective analysis was performed between January 2021 and December 2022 The clinical data of 121 patients with early lung cancer admitted to the hospital were collected. According to different surgical methods, they were divided into control group (n=59) and observation group (n=62). The observation group was given thoracoscopic subsegmentectomy, and the control group was given thoracoscopic segmentectomy. The perioperative indicators, inflammatory factors and complications were compared between the two groups. Results: The number of resected subsegments in the observation group was less than that in the control group.The levels of CRP and PCT in the observation group were lower than those in the control group. There was no significant difference in the incidence of complications, operation time, intraoperative blood loss, width of lesion margin, and length of hospital stay between the two groups. Conclusions: Thoracoscopic subsegmentectomy and thoracoscopic subsegmentectomy have the same surgical effect in the treatment of early stage lung cancer, but thoracoscopic subsegmentectomy can reduce the number of resected subsegments and reduce the inflammatory response after operation.
References
[1] LIU Haitao, YI Xiuxiu, Tian Jianhui. Research progress of LC Traditional Chinese and Western anticoagulant therapy [J]. Shaanxi
Traditional Chinese Medicine, 2020, 41 (1) : 127-130.
[2] Zhao Jing, Li Ming, Li Chuanying, et al. Relationship between pathology of early lung adenocarcinoma manifested as pulmonary
nodules and multiple driver genes [J]. Journal of Clinical Pulmonology, 2018,23 (8) : 1459-1463.
[3] Li Teng, Zhao Xin, Xu J En, et al. Dual-source CT low-dose scanning of pulmonary nodules and its diagnostic value in early lung
adenocarcinoma [J]. Chinese Journal of Digital Medicine, 2019,14 (10) : 16-18.
[4] Wu Weiming, Xia Yang, Xu Jing, et al. Comparative study of 3D assisted thoracoscopy combined with subsegmental pulmonary
resection in the treatment of pulmonary intersegmental nodules [J]. Journal of Nanjing Medical University (Natural Science Edition), 2018,38
(10) : 1424-1427.
[5] Liu Qiang, Li Zhihua, Wang Jun, et al. Safety and short-term efficacy of pulmonary subsegmental resection versus pulmonary seg_x005fmental resection in the treatment of early small nodular LC [J]. Journal of Nanjing Medical University (Natural Science Edition), 2019, 41 (8)
: 1190-1195.
[6] SUZUKI K, WATANABE S I, WAKABAYASHI M, et al. A single-arm study of sublobar resection for ground glass opacity
dominant peripheral lung cancer[J]. Journal of Thoracic and Cardiovascular Surgery, 2019, 163 (1) : 289-301.
[7] Wang Lilin, Zhang Jia, Fan Kun, et al. Advances in the treatment of non-small cell LC by pulmonary subsegmentectomy [J]. Modern Oncology Medicine, 2019, 28 (23) : 4190-4192.
[8] Zhu Yning, Li Zhihua, He Zhicheng, et al. Clinical comparative study of thoracoscopic pulmonary subsegment resection [J]. Journal of Nanjing Medical University (Natural Science Edition), 2019, 40 (6) : 870-874.
[9] Lin Yurong. Study on the relationship between cancer-related fatigue and serum CRP, IL-6, ACTH and cortisol in patients with LC
[J]. Journal of Clinical Pulmonology, 2018,23 (1) : 146-149. (in Chinese)
[10]Qin Ying. Effects of thoracoscopic lobectomy and sublobectomy on trauma indexes, immune indexes and therapeutic outcomes in
elderly patients with early non-small cell lung cancer [J]. Modern Medicine, 2019, 48 (4) : 496-499.
[11]Lu Yongbin, Teng Yongjun, Wei Ning, et al. Study on the correlation and interaction between serum procalcitonin and D-dimer and
LC [J]. Chinese Journal of Disease Control, 2018, 22 (9) : 933-937.
[12]Tang W S, Lin D H, Zheng H, et al. Relationship between serum PCT content and invasive growth and angiogenesis of cancer
cells in patients with small cell LC [J]. Journal of Hainan Medical College, 2018,24 (4) : 500-503.
Authors submitting to USP journals agree to publish their manuscript under the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0) where authors agree to allow third parties to share their work (copy, distribute, transmit) and to adapt it, under the condition that the authors are given credit, and that in the event of reuse or distribution, the terms of this license are made clear
Authors retain copyright of their work, with first publication rights (online and print) granted to Universe Scientific Publishing or the owner of the journal in question.
